Perspectives
Quintiles' insight on biopharmaceutical development and commercialization.
Quintiles has a unique perspective on the rapidly-changing needs of the bio pharmaceutical industry. The New Health of today presents fresh and difficult risks for bio pharma, but also brings unmatched opportunity for those who can navigate those risks and seize opportunities by adapting to a more innovative business model. This area is meant to provide our point-of view – our perspective – on how the various and complex issues facing the industry today can best be managed for clinical and commercial success.
View Perspectives by Topic
Featured White Paper
| PDF
Expected Growth of Industry-Sponsored Clinical Trials in the Middle East Benchmarked on other Global Regions
The evolving business model in the biopharmaceutical industry depends on increased productivity in clinical trials. This demands lower-cost, faster and more effective clinical trial processes.
Featured Podcast
Podcast: Strategic Drug Development in Asia
Sorry, your browser doesn't support the embedded player.
Dr. Amar Kureishi, Regional Chief Medical Officer, Asia, Quintiles, explains the drivers behind biopharma's need to establish new models for working in Asia.
